Arguments for the screening of essential viral markers in the context of chronic hemodialysis patient surveillance
Nephrol Ther. 2024 May 15;20(2):156-159. doi: 10.1684/ndt.2024.73.NO ABSTRACTPMID:38742300 | DOI:10.1684/ndt.2024.73 (Source: Nephrologie and Therapeutique)
Source: Nephrologie and Therapeutique - May 14, 2024 Category: Urology & Nephrology Authors: Vincent Thibault Source Type: research

Argument for the annual monitoring of specialized biological examinations carried out in hemodialysis
Nephrol Ther. 2024 May 15;20(2):147-154. doi: 10.1684/ndt.2024.75.NO ABSTRACTPMID:38742297 | DOI:10.1684/ndt.2024.75 (Source: Nephrologie and Therapeutique)
Source: Nephrologie and Therapeutique - May 14, 2024 Category: Urology & Nephrology Authors: Antoine Braconnier Lucile Mercadal Jean-Michel Poux Source Type: research

Argument justifying the measurement of routine biochemical markers in hemodialysis
Nephrol Ther. 2024 May 15;20(2):143-146. doi: 10.1684/ndt.2024.74.NO ABSTRACTPMID:38742304 | DOI:10.1684/ndt.2024.74 (Source: Nephrologie and Therapeutique)
Source: Nephrologie and Therapeutique - May 14, 2024 Category: Urology & Nephrology Authors: C éline Nodimar Philippe Chauveau Source Type: research

Second wave of the repository of biological examinations in hemodialysis
Nephrol Ther. 2024 May 15;20(2):141-142. doi: 10.1684/ndt.2024.76.NO ABSTRACTPMID:38742303 | DOI:10.1684/ndt.2024.76 (Source: Nephrologie and Therapeutique)
Source: Nephrologie and Therapeutique - May 14, 2024 Category: Urology & Nephrology Authors: Thierry Lobbedez Jean-Michel Poux Source Type: research

Arguments for the screening of essential viral markers in the context of chronic hemodialysis patient surveillance
Nephrol Ther. 2024 May 15;20(2):156-159. doi: 10.1684/ndt.2024.73.NO ABSTRACTPMID:38742300 | DOI:10.1684/ndt.2024.73 (Source: Nephrologie and Therapeutique)
Source: Nephrologie and Therapeutique - May 14, 2024 Category: Urology & Nephrology Authors: Vincent Thibault Source Type: research

Argument for the annual monitoring of specialized biological examinations carried out in hemodialysis
Nephrol Ther. 2024 May 15;20(2):147-154. doi: 10.1684/ndt.2024.75.NO ABSTRACTPMID:38742297 | DOI:10.1684/ndt.2024.75 (Source: Nephrologie and Therapeutique)
Source: Nephrologie and Therapeutique - May 14, 2024 Category: Urology & Nephrology Authors: Antoine Braconnier Lucile Mercadal Jean-Michel Poux Source Type: research

Argument justifying the measurement of routine biochemical markers in hemodialysis
Nephrol Ther. 2024 May 15;20(2):143-146. doi: 10.1684/ndt.2024.74.NO ABSTRACTPMID:38742304 | DOI:10.1684/ndt.2024.74 (Source: Nephrologie and Therapeutique)
Source: Nephrologie and Therapeutique - May 14, 2024 Category: Urology & Nephrology Authors: C éline Nodimar Philippe Chauveau Source Type: research

Second wave of the repository of biological examinations in hemodialysis
Nephrol Ther. 2024 May 15;20(2):141-142. doi: 10.1684/ndt.2024.76.NO ABSTRACTPMID:38742303 | DOI:10.1684/ndt.2024.76 (Source: Nephrologie and Therapeutique)
Source: Nephrologie and Therapeutique - May 14, 2024 Category: Urology & Nephrology Authors: Thierry Lobbedez Jean-Michel Poux Source Type: research

Arguments for the screening of essential viral markers in the context of chronic hemodialysis patient surveillance
Nephrol Ther. 2024 May 15;20(2):156-159. doi: 10.1684/ndt.2024.73.NO ABSTRACTPMID:38742300 | DOI:10.1684/ndt.2024.73 (Source: Nephrologie and Therapeutique)
Source: Nephrologie and Therapeutique - May 14, 2024 Category: Urology & Nephrology Authors: Vincent Thibault Source Type: research

Argument for the annual monitoring of specialized biological examinations carried out in hemodialysis
Nephrol Ther. 2024 May 15;20(2):147-154. doi: 10.1684/ndt.2024.75.NO ABSTRACTPMID:38742297 | DOI:10.1684/ndt.2024.75 (Source: Nephrologie and Therapeutique)
Source: Nephrologie and Therapeutique - May 14, 2024 Category: Urology & Nephrology Authors: Antoine Braconnier Lucile Mercadal Jean-Michel Poux Source Type: research

Measuring congestion with a non ‐invasive monitoring device in heart failure and haemodialysis: CONGEST‐HF
ConclusionsA non-invasive device was able to detect changes in congestion in patients with HF receiving decongestion therapy and patients having fluid removed at haemodialysis. The cardiopulmonary management device, which measures multiple parameters, is a potentially useful tool to monitor patients with HF to prevent hospitalizations. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - May 14, 2024 Category: Cardiology Authors: James P. Curtain, Atefeh Talebi, Alasdair McIntosh, Alex McConnachie, Joanne O'Donnell, Paul Welsh, Joanna Osmanska, Matthew M.Y. Lee, Piotr Sonecki, Tony Akl, Joohyun Seo, Venugopal Gopinathan, Jed Hurwitz, Srikanth Thiagarajan, Stephen Pet Tags: Research Article Source Type: research

Hemoglobin level and erythropoietin response in hemodialysis patients: what can we pay attention to?
Ren Fail. 2024 Dec;46(1):2353338. doi: 10.1080/0886022X.2024.2353338. Epub 2024 May 13.NO ABSTRACTPMID:38738531 | DOI:10.1080/0886022X.2024.2353338 (Source: Renal Failure)
Source: Renal Failure - May 13, 2024 Category: Urology & Nephrology Authors: Yu Zhao Kun Zhao Jingchen Fang Wenyun Wang Source Type: research

Dialysis parameters associated with SARS-CoV-2 infection and prognosis in end-stage kidney disease
CONCLUSION: Acute Covid-19 illness is associated with variations in dialysis parameters of volume status in patients with ESKD. Furthermore, increases in predialysis BP during acute Covid-19 illness are associated with an adverse prognosis in Covid-ESKD patients.PMID:38738416 | DOI:10.1080/07853890.2024.2343890 (Source: Annals of Medicine)
Source: Annals of Medicine - May 13, 2024 Category: Internal Medicine Authors: Rodrigo Bezerra Audes D M Feitosa Odilson M Silvestre Miguel M Fernandes-Silva Roberto B Amazonas Flavio Teles Cibele I S Rodrigues Jose L Lima-Filho Andrei C Sposito Wilson Nadruz Source Type: research

A chronic intermittent haemodialysis pig model for functional evaluation of dialysis membranes
In conclusion, this model mimics the pathophysiology and dialysis condition of patients undergoing haemodialysis. This dialysis treatment model of renal failure will be useful for evaluating the performance and safety of dialysis membranes.PMID:38738648 | DOI:10.1177/03913988241253152 (Source: The International Journal of Artificial Organs)
Source: The International Journal of Artificial Organs - May 13, 2024 Category: Transplant Surgery Authors: Shushi Yamamoto Hiroshi Umeno Yusuke Sano Masahide Koremoto Yoshimichi Goda Yasuyuki Kaneko Shidow Torisu Toshihiro Tsuruda Shouichi Fujimoto Source Type: research

Hemoglobin level and erythropoietin response in hemodialysis patients: what can we pay attention to?
Ren Fail. 2024 Dec;46(1):2353338. doi: 10.1080/0886022X.2024.2353338. Epub 2024 May 13.NO ABSTRACTPMID:38738531 | DOI:10.1080/0886022X.2024.2353338 (Source: Renal Failure)
Source: Renal Failure - May 13, 2024 Category: Urology & Nephrology Authors: Yu Zhao Kun Zhao Jingchen Fang Wenyun Wang Source Type: research